Beijing Science Sun Pharmaceutical Co.,Ltd.’s Net Profit Dropped 22.7% in First Three Quarters of 2023

Beijing Science Sun Pharmaceutical Co.,Ltd. (北京赛升药业股份有限公司) (300485.SZ) reported a net profit of 193.3 million yuan in the first three quarters of 2023, down 22.7% year-on-year.

Meanwhile, the company posted 393.8 million yuan in revenue, down 34.3% year-on-year.

At the end of the reporting period, it had 3.7 billion yuan in total assets and 139.3 million yuan in total liabilities, with a liability-to-asset ratio of 3.8%.